- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.12. | Zealand Pharma and OTR to develop metabolic disease therapeutics | ||
| 11.12. | Novartis and UK-based Relation forge R&D deal worth up to $1.7bn | ||
| 11.12. | Moderna signs deal worth up to $503m with Nanexa | ||
| 11.12. | UK slashes 2026 drug rebate rate by one-third to win back pharma sentiments | ||
| 11.12. | Pfizer plans job cuts in Switzerland to reduce expenses | ||
| 11.12. | Boehringer's Jascayd gains China's NMPA approval for PPF | ||
| 11.12. | Formation Bio gains global rights to Lynk Pharma's TYK2 inhibitor | ||
| 10.12. | Cell and gene therapy investment strategy pivots as funding dries up | ||
| 10.12. | Eli Lilly picks Alabama as home to $6bn orforglipron manufacturing facility | ||
| 10.12. | Formycon and Zydus sign exclusive agreement for FYB206 supply | ||
| 10.12. | Health Canada approves Biogen's Zurzuvae for PPD treatment | ||
| 09.12. | BIOSECURE Act set for Congress vote after inclusion in annual defence bill | ||
| 09.12. | Mirum to buy Bluejay for up to $820m in rare liver disease push | ||
| 09.12. | Pfizer gains another obesity asset with $2bn deal for YaoPharma's GLP-1RA | ||
| 09.12. | EC approves Roche's Gazyva to treat active lupus nephritis | ||
| 09.12. | Inductive Bio gains $21m ARPA-H funds for drug prediction models | ||
| 08.12. | Medical bodies sound alarm over US hepatitis B vaccine vote | ||
| 08.12. | Viatris signs agreements with Biocon on $815m stake sale | ||
| 08.12. | Agilent and Monash University Malaysia to set up biodiscovery hub | ||
| 05.12. | CDC panel votes to revoke newborn hepatitis B vaccine recommendation | ||
| 05.12. | Crescent and Kelun-Biotech swap cancer asset rights in double deal | ||
| 05.12. | Denali makes $275m funding agreement with Royalty Pharma | ||
| 05.12. | Takeda and Innovent fulfil close conditions for ADC and IO therapies | ||
| 04.12. | Former FDA commissioners unite to condemn US vaccine proposals | ||
| 04.12. | FDA appoints Tracy Beth Høeg as fifth CDER head this year |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .